feed,title,long_url,short_url
Benzinga,FDA Accepts AbbVie's Atogepant US Review Application For Migraine,https://benzinga.com/general/biotech/21/03/20400475/fda-accepts-abbvies-atogepant-us-review-application-for-migraine,https://j.mp/3fxjY3L
